Migvax, which had already developed a vaccine for a strain of coronavirus that affects chickens, is making headway into developing an oral vaccine for humans.
Competing with other countries around the world to develop a vaccine against COVID-19, Israeli company MixVax has appointed a ‘heavyweight’ in the pharmaceutical world, Eyal Desheh, as its new chairman.
Desheh discusses the process with i24 News, saying that if all goes well, it should be a matter of just months before testing on humans can begin.
“We’re hopeful,” Desheh says.
HELP ISRAELIS BATTLE CORONA!
Donate to the Corona Emergency Relief Fund. Coronavirus has taken a huge toll on the people of Israel. The poor, elderly and ill are most vulnerable.
Israeli soldiers, security officers and medical care providers operate under great danger and risk to life.